Kronos Bio, Inc.盘中异动下午盘股价大涨6.00%报1.060美元

市场透视2025-01-24

北京时间2025年01月24日02时22分，Kronos Bio, Inc.（KRON.us）股票出现异动，股价大幅拉升6.00%。截至发稿，该股报1.060美元/股，成交量7.2814万股，换手率0.12%，振幅3.50%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.71倍。机构评级方面，在所有1家...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2505069044?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-24 02:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2505069044","market":"us","top_or_hot":-1,"title":"Kronos Bio, Inc.盘中异动 下午盘股价大涨6.00%报1.060美元","media":"市场透视","content":"<div>\n<p>北京时间2025年01月24日02时22分，Kronos Bio, Inc.（KRON.us）股票出现异动，股价大幅拉升6.00%。截至发稿，该股报1.060美元/股，成交量7.2814万股，换手率0.12%，振幅3.50%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.71倍。机构评级方面，在所有1家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124022259abb62811&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kronos Bio, Inc.盘中异动 下午盘股价大涨6.00%报1.060美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKronos Bio, Inc.盘中异动 下午盘股价大涨6.00%报1.060美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-24 02:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124022259abb62811&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年01月24日02时22分，Kronos Bio, Inc.（KRON.us）股票出现异动，股价大幅拉升6.00%。截至发稿，该股报1.060美元/股，成交量7.2814万股，换手率0.12%，振幅3.50%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.71倍。机构评级方面，在所有1家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124022259abb62811&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4505","symbol_name":"高瓴资本持仓","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124022259abb62811&s=b","article_id":"2505069044","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124022259abb62811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2505069044","pubTimestamp":1737656578,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年01月24日02时22分，Kronos Bio, Inc.股票出现异动，股价大幅拉升6.00%。截至发稿，该股报1.060美元/股，成交量7.2814万股，换手率0.12%，振幅3.50%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4505":"高瓴资本持仓","BK4139":"生物科技","KRON":"Kronos Bio, Inc."},"translate_title":"Kronos Bio, Inc. 's intraday change surged 6.00% to $1.060 in afternoon trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KRON":1},"content_text":"北京时间2025年01月24日02时22分，Kronos Bio, Inc.（KRON.us）股票出现异动，股价大幅拉升6.00%。截至发稿，该股报1.060美元/股，成交量7.2814万股，换手率0.12%，振幅3.50%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.71倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts (To Pur Com)、Nutriband Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5493.09%、3789.33%、692.99%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts (To Pur Com)、Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)，振幅分别为929.64%、144.39%、84.55%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。该公司在一个业务部门运营，即生物制药产品的开发。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2505069044","isCrawlerRequest":true}

Kronos Bio, Inc.盘中异动 下午盘股价大涨6.00%报1.060美元

精彩评论

Kronos Bio, Inc.盘中异动下午盘股价大涨6.00%报1.060美元